(Z)-3-((4-(3-((4-methylpiperazine-1-yl)methyl)-2-oxopyrrolidin-1-)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate

ID: ALA4166187

PubChem CID: 136299423

Max Phase: Preclinical

Molecular Formula: C33H35N5O4

Molecular Weight: 565.67

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2CCC(CN3CCN(C)CC3)C2=O)cc1)c1ccccc1

Standard InChI:  InChI=1S/C33H35N5O4/c1-36-16-18-37(19-17-36)21-24-14-15-38(32(24)40)26-11-9-25(10-12-26)34-30(22-6-4-3-5-7-22)29-27-13-8-23(33(41)42-2)20-28(27)35-31(29)39/h3-13,20,24,34H,14-19,21H2,1-2H3,(H,35,39)/b30-29-

Standard InChI Key:  VPZDWQHUUTZTSQ-FLWNBWAVSA-N

Molfile:  

     RDKit          2D

 42 47  0  0  0  0  0  0  0  0999 V2000
    5.1329  -14.8497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1317  -15.6693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8398  -16.0782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8380  -14.4409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5466  -14.8461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5514  -15.6693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3358  -15.9191    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8158  -15.2503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3280  -14.5872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6330  -15.2455    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5759  -13.8086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3742  -13.6340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0256  -13.2045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2770  -12.4274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7274  -11.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9281  -11.9980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6814  -12.7815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2326  -13.3819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4237  -16.0773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7163  -15.6681    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4230  -16.8945    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0083  -16.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6222  -12.8553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4192  -12.6842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3147  -11.4795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0704  -12.2571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1166  -11.3014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6657  -11.9058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3611  -10.5257    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1365  -10.2679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1310   -9.4508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3521   -9.2035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8763   -9.8679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0591   -9.8734    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0942   -8.4280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6369   -7.8170    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4414   -7.9887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9831   -7.3816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7292   -6.6109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9282   -6.4390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3811   -7.0485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2754   -6.0030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  8 10  2  0
  9 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  2 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 12 23  1  0
 23 24  2  0
 24 28  1  0
 27 25  1  0
 25 26  2  0
 26 23  1  0
 27 28  2  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 29  1  0
 27 29  1  0
 33 34  2  0
 32 35  1  0
 35 36  1  0
 36 37  1  0
 36 41  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 39 42  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4166187

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pdgfrb Platelet-derived growth factor receptor (285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 565.67Molecular Weight (Monoisotopic): 565.2689AlogP: 4.01#Rotatable Bonds: 7
Polar Surface Area: 94.22Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.86CX Basic pKa: 8.42CX LogP: 3.10CX LogD: 2.04
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.33Np Likeness Score: -0.82

References

1. Huang Z, Li H, Zhang Q, Lu F, Hong M, Zhang Z, Guo X, Zhu Y, Li S, Liu H..  (2017)  Discovery of Indolinone-Based Multikinase Inhibitors as Potential Therapeutics for Idiopathic Pulmonary Fibrosis.,  (11): [PMID:29152045] [10.1021/acsmedchemlett.7b00164]
2. Huang Z, Li H, Zhang Q, Lu F, Hong M, Zhang Z, Guo X, Zhu Y, Li S, Liu H..  (2017)  Discovery of Indolinone-Based Multikinase Inhibitors as Potential Therapeutics for Idiopathic Pulmonary Fibrosis.,  (11): [PMID:29152045] [10.1021/acsmedchemlett.7b00164]
3. Huang Z, Li H, Zhang Q, Lu F, Hong M, Zhang Z, Guo X, Zhu Y, Li S, Liu H..  (2017)  Discovery of Indolinone-Based Multikinase Inhibitors as Potential Therapeutics for Idiopathic Pulmonary Fibrosis.,  (11): [PMID:29152045] [10.1021/acsmedchemlett.7b00164]

Source